Key result
Carotid PVAT attenuation on CTA fails to identify culprit lesions or correlate with plaque inflammation.
Why the study?
Perivascular adipose tissue density on CT angiography is an emerging biomarker of coronary inflammation, but whether this concept extends to capturing plaque inflammation and vulnerability in carotid atherosclerosis was unclear.
Does perivascular adipose tissue (PVAT) attenuation measured on routine CT angiography differentiate symptomatic culprit carotid plaques from non-culprit plaques or correlate with histological and molecular markers of plaque inflammation and vulnerability in patients with carotid atherosclerosis?
Observational (n=148)
No
Does perivascular adipose tissue (PVAT) attenuation measured on routine CT angiography differentiate symptomatic culprit carotid plaques from non-culprit plaques or correlate with histological and molecular markers of plaque inflammation and vulnerability in patients with carotid atherosclerosis?
Unlike in coronary arteries, CTA-derived perivascular adipose tissue (PVAT) attenuation around the carotid artery does not distinguish symptomatic culprit plaques or correlate with histological macrophage infiltration and inflammatory cytokines, challenging its utility as a non-invasive biomarker of local carotid plaque inflammation.
Carotid PVAT attenuation lacks association with culprit lesions or macrophages; challenges coronary biomarker assumptions and leaves open its clinical utility.
Background and Aims Quantifying arterial inflammation can augment risk stratification and drug development in atherosclerosis. While perivascular adipose tissue (PVAT) density, captured as fat attenuation index (FAI) on CT angiography (CTA), is an emerging biomarker of coronary inflammation, it remains unclear whether this concept extends to carotid atherosclerosis. Methods Using routine CTA data from hospital-based stroke cohorts, we developed a pipeline to quantify attenuation metrics of PVAT surrounding the distal common and proximal internal carotid arteries. We compared PVAT metrics between culprit and contralateral non-culprit plaques in patients with symptomatic carotid atherosclerosis and between culprit plaques and control carotid segments from patients without symptomatic atherosclerosis. In patients undergoing carotid endarterectomy, we assessed associations of CTA-derived PVAT metrics with histological and proteomic markers of plaque inflammation and stability. Results Across 107 patients with symptomatic carotid atherosclerosis (75.5±8.7 years; 63% men), PVAT attenuation metrics did not show significant differences between culprit and contralateral non-culprit lesions (all p>0.2). We also found no evidence for higher PVAT attenuation in culprit lesions, when compared to arteries of patients without symptomatic atherosclerosis. In 82 patients undergoing endarterectomy, pre-operative CTA-derived metrics of PVAT attenuation showed no significant correlations with CD68+ macrophage areas in excised plaques (r -0.11 to 0.07, all p>0.3). Similarly, no PVAT attenuation metrics were associated with thinner fibrous cap or higher plaque levels of pro-inflammatory cytokines (IL-6, TNF). Conclusions In contrast to coronary atherosclerosis, carotid PVAT attenuation was not associated with symptomatic culprit lesions or histological and molecular markers of plaque inflammation and vulnerability. Structured Graphical Abstract Key Question Can perivascular adipose tissue (PVAT) attenuation on CT, proposed as a marker of coronary artery inflammation, also capture atherosclerotic plaque inflammation and vulnerability in the carotid arteries? Key Finding In 107 patients with carotid atherosclerosis-associated stroke, PVAT attenuation did not differ between culprit and contralateral non-culprit lesions and was not associated with histopathological or molecular markers of plaque inflammation and vulnerability. Take-home Message PVAT attenuation did not capture local carotid plaque inflammation or vulnerability in this cohort, questioning the transferability of this CT-based marker from coronary to carotid atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Mayrhofer et al. (2026) conducted an observational in Carotid atherosclerosis (n=148). CT angiography-derived perivascular adipose tissue (PVAT) attenuation metrics in culprit carotid plaques vs. Contralateral non-culprit carotid lesions and histological/proteomic markers of plaque inflammation was evaluated on Difference in PVAT attenuation metrics between culprit and contralateral non-culprit lesions, and correlation with CD68+ macrophage plaque areas (r -0.11 to 0.07, p=>0.2). Carotid PVAT attenuation on CTA did not differ between culprit and contralateral non-culprit lesions (p>0.2) or correlate with CD68+ macrophage areas (r -0.11 to 0.07, p>0.3).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: